Complete clearance of Ph+ metaphases after 3 months is a very early indicator of good response to imatinib as front-line treatment in chronic myelogenous leukemia.
Latagliata R, Isidori A, Breccia M, Carmosino I, Vozella F, Volpicelli P, Finsinger P, Barulli S, Loglisci G, Santopietro M, Federico V, Diverio D, Nanni M, Mancini M, Visani G, Alimena G.
Latagliata R, et al. Among authors: diverio d.
Acta Haematol. 2013;129(2):126-34. doi: 10.1159/000343384. Epub 2012 Nov 28.
Acta Haematol. 2013.
PMID: 23207803
Free article.